Amgen Inc. buy Royal Bank of Canada
Start price
07.04.26
/
50%
€292.40
Target price
07.04.27
€320.90
Performance (%)
14.03%
Price
27.07.26
€330.90
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 14.03%. A total of €2.52 was paid as dividends for this prediction. This prediction currently runs until 07.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.295% | 3.295% |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (AMGN) had its price target raised by Royal Bank Of Canada from $360.00 to $370.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat